Fanconi Anemia

ተከተል
Illustration of a Stanford researcher with briquilimab antibody vial in a lab, representing a new stem cell transplant method for Fanconi anemia.
በ AI የተሰራ ምስል

Stanford antibody regimen enables stem cell transplants without radiation or busulfan in Fanconi anemia

በAI የተዘገበ በ AI የተሰራ ምስል እውነት ተፈትሸ

A Stanford Medicine team reports that a single dose of the anti‑CD117 antibody briquilimab allowed three children with Fanconi anemia to undergo stem cell transplants without radiation or busulfan, achieving near‑complete donor cell engraftment in a phase 1b study published in Nature Medicine.

ይህ ድረ-ገጽ ኩኪዎችን ይጠቀማል

የእኛን ጣቢያ ለማሻሻል ለትንታኔ ኩኪዎችን እንጠቀማለን። የእኛን የሚስጥር ፖሊሲ አንብቡ የሚስጥር ፖሊሲ ለተጨማሪ መረጃ።
ውድቅ አድርግ